Trial · NCT03067441
Adverse events669
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 669
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo; Bempedoic Acid | 33 | 492 | |
| other | Nasopharyngitis | Infections and infestations | Bempedoic Acid; Bempedoic Acid | 86 | 970 | |
| other | Nasopharyngitis | Infections and infestations | OLE Bempedoic Acid | 119 | 1,462 | |
| other | Urinary tract infection | Infections and infestations | Placebo; Bempedoic Acid | 40 | 492 | |
| other | Urinary tract infection | Infections and infestations | Bempedoic Acid; Bempedoic Acid | 49 | 970 | |
| other | Urinary tract infection | Infections and infestations | OLE Bempedoic Acid | 89 | 1,462 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo; Bempedoic Acid | 30 | 492 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Bempedoic Acid; Bempedoic Acid | 38 | 970 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | OLE Bempedoic Acid | 68 | 1,462 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo; Bempedoic Acid | 18 | 492 | |
| other | Upper respiratory tract infection | Infections and infestations | Bempedoic Acid; Bempedoic Acid | 49 | 970 | |
| other | Upper respiratory tract infection | Infections and infestations | OLE Bempedoic Acid | 67 | 1,462 | |
| serious | Coronary artery disease | Cardiac disorders | Placebo; Bempedoic Acid | 3 | 492 | |
| serious | Coronary artery disease | Cardiac disorders | Bempedoic Acid; Bempedoic Acid | 15 | 970 | |
| serious | Coronary artery disease | Cardiac disorders | OLE Bempedoic Acid | 18 | 1,462 | |
| serious | Angina pectoris | Cardiac disorders | Placebo; Bempedoic Acid | 5 | 492 | |
| serious | Angina pectoris | Cardiac disorders | Bempedoic Acid; Bempedoic Acid | 9 | 970 | |
| serious | Angina pectoris | Cardiac disorders | OLE Bempedoic Acid | 14 | 1,462 | |
| serious | Atrial fibrillation | Cardiac disorders | Placebo; Bempedoic Acid | 2 | 492 | |
| serious | Atrial fibrillation | Cardiac disorders | Bempedoic Acid; Bempedoic Acid | 12 | 970 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03067441/events